Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1337-1344

  Teixeira Filho, Fabio Lopes ^a   Baracat, Edmund Chada ^a   Lee, Taek Hoo ^b   Suh, Chang Suk ^c   Matsui, Motozumi ^d   Chang, R Jeffrey ^d   Shimasaki, Shunichi ^d   Erickson, Gregory F ^d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Kyungpook National University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; GROWTH DIFFERENTIATION FACTOR 9; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; GENETIC CODE; HUMAN; IN SITU HYBRIDIZATION; OOCYTE; OOCYTE DEVELOPMENT; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALIA; FALLOPIA;

EID: 0036962187     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8316     Document Type: Article

References (53)

1. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss 3rd JF, Dunaif A 1998 Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 53:217-256
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study, J Clin Endocrinol Metab 83:3078-3082
3. Dunaif A, Givens JR, Haseltine FP, Merriam GR 1992 Polycystic ovary syndrome. London: Blackwell Scientific Publications, Inc.; 392
4. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
5. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
6. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
7. Jacobs HS 1987 Polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 1:113-131
8. Erickson GF 1991 Folliculogenesis in polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome, current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publishers; 111-142
9. Hughesdon PE 1982 Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis." Obstet Gynecol Surv 37:59-77
10. Goldzieher JW, Green JA 1962 The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 22:325-338
11. Erickson GF 1995 PCO: the ovarian connection. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Raven Press; 1141-1160
12. Goldzieher JW, Axelrod LR 1963 Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14:631-653
13. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C 1985 The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 6:371-399
14. Gilling-Smith C, Willis DS, Beard RW, Franks S 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79:1158-1165
15. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
16. McPherron AC, Lee S-J 1993 GDF-3 and GDF-9: two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J Biol Chem 268:3444-3449
17. McGrath SA, Esquela AF, Lee S-J 1995 Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 9:131-136
18. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809-1817
19. Laitinen M, Vuojolainen K, Jaatinen R, Ketola I, Aaltonen J, Lehtonen E, Heikinheimo M, Ritvos O 1998 A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 78:135-140
20. Eppig JJ, Chesnel F, Hirao Y, O'Brien MJ, Pendola FL, Watanabe S, Wigglesworth K 1997 Oocyte control of granulosa cell development: how and why. Hum Reprod 12:127-132
21. Matzuk M 2000 Revelations of ovarian follicle biology from gene knockout mice, Mol Cell Endocrinol 163:61-66
22. Erickson GF, Shimasaki S 2000 The role of the oocyte in folliculogenesis. Trends Endocrinol Metab 11:193-198
23. Fitzpatrick SL, Sindoni DM, Shughrue PJ, Lane MV, Merchenthaler IJ, Frail DE 1998 Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues. Endocrinology 139:2571-2578
24. Jaatinen R, Laitinen M, Vuojolainen K, Aaltonen J, Louhio H, Heikinheimo K, Lehtonen E, Ritvos O 1999 Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B. Mol Cell Endocrinol 156:189-193
25. Bodensteiner KJ, Clay CM, Moeller CL, Sawyer HR 1999 Molecular cloning of the ovine growth/differentiation factor-9 gene and expression of growth/differentiation factor-9 in ovine and bovine ovaries. Biol Reprod 60:381-386
26. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk M 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535
27. Elvin JA, Yah C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034
28. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF 1998 Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 204:373-384
29. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O 2000 Mutations in art oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosagesensitive manner. Nat Genet 25:279-283
30. Aaltonen J, Laitinen MP, Vuojolainen K, Jaatinen R, Horelli-Kuitunen N, Seppa L, Louhio H, Tuuri T, Sjoberg J, Butzow R, Hovata O, Dale L, Ritvos O 1999 Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 84:2744-2750
31. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320-1329
32. DeVane GW, Czekala NM, Judd HL, Yen SSC 1975 Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121:496-500
33. Hourvitz A, Widget AE, Teixeira Filho FL, Chang RJ, Adashi EY, Erickson GF 2000 Pregnancy-associated plasma protein - a gene expression in human ovaries is restricted to healthy follicles and corpora lutea. J Clin Endocrinol Metab 85:4916-4919
34. Haendler B, Hofer E 1990 Characterization of the human cyclophilin gene and of related processed pseudogenes. Eur J Biochem 190:477-482
35. Erickson GF 2000 Follicle growth and development. In: Sciarra JJ, ed. Gynecology and obstetrics. Philadelphia: Lipincott-Raven; 1-30
36. Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE, Hsueh AJ, Vale W 1988 Rapid changes in the expression of inhibin α-, βA-, and βB-subunits in ovarian cell types during the rat estrous cycle. Mol Endocrinol 2:1352-1363
37. Nakatani A, Shimasaki S, DePaolo LV, Erickson GF, Ling N 1991 Cyclic changes in follistatin gene expression and translation in the rat ovary during the estrous cycle. Endocrinology 129:603-611
38. Erickson GF, Kokka S, Rivier C 1995 Activin causes premature superovulation. Endocrinology 136:4804-4813
39. Wyllie AH 1980 Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306
40. Otsuka F, Yao Z, Lee TH, Yamamoto S, Erickson GF, Shimasaki S 2000 Bone morphogenetic protein-15: identification of target cells and biological functions. J Biol Chem 275:39523-39528
41. Bachvarova R 1981 Synthesis, turnover, and stability of heterogeneous RNA in growing mouse oocytes. Dev Biol 86:384-392
42. Bachvarova RF 1992 A maternal tail of poly(A): the long and the short of it. Cell 69:895-897
43. Brower PT, Gizang E, Boreen SM, Schultz RM 1981 Biochemical studies of mammalian oogenesis: synthesis and stability of various classes of RNA during growth of the mouse oocyte in vitro. Dev Biol 86:373-383
44. Huarte J, Stutz A, O'Connell ML, Gubler P, Belin D, Darrow AL, Strickland S, Vassalli JD 1992 Transient translational silencing by reversible mRNA deadenylation. Cell 69:1021-1030
45. Philpott CC, Ringuette MJ, Dean J 1987 Oocyte-specific expression and developmental regulation of ZP3, the sperm receptor of the mouse zona pellucida. Dev Biol 121:568-575
46. Huarte J, Belin D, Vassalli JD 1985 Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation. Cell 43:551-558
47. Hayashi M, McGee EA, Min G, Klein C, Rose UM, van Duin M, Hsueh AJ 1999 Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 140:1236-1244
48. Vitt UA, McGee EA, Hayashi M, Hsueh AJW 2000 In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 141:3814-3820
49. Joyce IM, Clark AT, Pendola FL, Eppig JJ 2000 Comparison of recombinant growth differentiation factor-9 and oocyte regulation of KIT ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol Reprod 63:1669-1675
50. Vitt UA, Hayashi M, Klein C, Hsueh AJW 2000 Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62:370-377
51. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM 1999 Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13:1035-1048
52. Elvin JA, Yan C, Matzuk MM 2000 Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci USA 97:10288-10293
53. Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, Hsueh AJ, Tsafriri A 2000 Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod 63:1214-1218